Salmeterol and fluticasone propionate (50/250 μg) administered via combination Diskus inhaler: As effective as when given via separate Diskus inhalers

Canadian Respiratory Journal

Volumn 6, Issue 1, 1999, Pages 45-51

  Chapman, Kenneth R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Asthma; Combination therapy; Fluticasone propionate; Salmeterol

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO; SALMETEROL; SALMETEROL PLUS FLUTICASONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPHONIA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HOARSENESS; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SYMPTOM; THORAX DISEASE; TREMOR; VERTIGO;

EID: 0032923812     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/894803     Document Type: Article

References (2)

1. Chervinsky P, van-As A, Bronsky EA, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994;94:676-83.
2. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax 1993;48:817-23.